Quick Answer
Bergamot Lipid Profile Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Bergamot ( Citrus bergamia ), a flavonoid-rich nutraceutical, has shown potential cardiometabolic benefits, yet evidence from human trials remains inconsistent.
Key Takeaways
- 01Bergamot ( Citrus bergamia ), a flavonoid-rich nutraceutical, has shown potential cardiometabolic benefits, yet evidence from human trials remains inconsistent. [Chambari M (2026)]
- 02This systematic review and dose-response meta-analysis evaluated the effects of bergamot ( Citrus bergamia ) on cardiovascular disease risk factors in adults. [Chambari M (2026)]
- 03The certainty of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. [Chambari M (2026)]
- 04Introduction According to the common definition, nutraceuticals are components found in food that can act as therapeutic substances. [Morze J (2020)]
The current Migaku evidence database contains 2 reusable source documents for Bergamot Lipid Profile Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts.
- Bergamot ( Citrus bergamia ), a flavonoid-rich nutraceutical, has shown potential cardiometabolic benefits, yet evidence from human trials remains inconsistent. [Chambari M (2026); evidence level 1]
- This systematic review and dose-response meta-analysis evaluated the effects of bergamot ( Citrus bergamia ) on cardiovascular disease risk factors in adults. [Chambari M (2026); evidence level 1]
- The certainty of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. [Chambari M (2026); evidence level 1]
- Introduction According to the common definition, nutraceuticals are components found in food that can act as therapeutic substances. [Morze J (2020); evidence level 1]
- Each stage of the review, including the study section, data extraction, and risk of bias and quality of evidence assessments, will be performed in duplicate. [Morze J (2020); evidence level 1]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources